<VariationArchive VariationID="634634" VariationName="NM_144772.3(NAXE):c.326dup (p.Thr110fs)" VariationType="Duplication" Accession="VCV000634634" Version="11" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-19" DateCreated="2019-06-17" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="622304" VariationID="634634">
      <GeneList>
        <Gene Symbol="NAXE" FullName="NAD(P)HX epimerase" GeneID="128240" HGNC_ID="HGNC:18453" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="156591776" stop="156594299" display_start="156591776" display_stop="156594299" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_025791758.1" start="150333" stop="152856" display_start="150333" display_stop="152856" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="156561557" stop="156564090" display_start="156561557" display_stop="156564090" Strand="+" />
          </Location>
          <OMIM>608862</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_144772.3(NAXE):c.326dup (p.Thr110fs)</Name>
      <CanonicalSPDI>NC_000001.11:156592393:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="156592393" stop="156592394" display_start="156592393" display_stop="156592394" variantLength="1" positionVCF="156592393" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="156562185" stop="156562186" display_start="156562185" display_stop="156562186" variantLength="1" positionVCF="156562185" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>T110fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.156562191dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.156562191dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.156592399dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.156592399dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052542.1" sequenceAccession="NG_052542" sequenceVersion="1" change="g.5634dup">
            <Expression>NG_052542.1:g.5634dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144772.3" sequenceAccession="NM_144772" sequenceVersion="3" change="c.326dup" MANESelect="true">
            <Expression>NM_144772.3:c.326dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_658985.2" sequenceAccession="NP_658985" sequenceVersion="2" change="p.Thr110fs">
            <Expression>NP_658985.2:p.Thr110fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144772.2" sequenceAccession="NM_144772" sequenceVersion="2" change="c.326dupC">
            <Expression>NM_144772.2:c.326dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="779820587" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_144772.3(NAXE):c.326dup (p.Thr110fs) AND Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1" Accession="RCV000785167" Version="8">
        <ClassifiedConditionList TraitSetID="33246">
          <ClassifiedCondition DB="MedGen" ID="C4310675">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2019-11-01" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144772.3(NAXE):c.326dup (p.Thr110fs) AND Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy" Accession="RCV001267663" Version="1">
        <ClassifiedConditionList TraitSetID="63859">
          <ClassifiedCondition DB="MedGen" ID="CN263076">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144772.3(NAXE):c.326dup (p.Thr110fs) AND not provided" Accession="RCV001873197" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144772.3(NAXE):c.326dup (p.Thr110fs) AND NAXE-related disorder" Accession="RCV003411725" Version="4">
        <ClassifiedConditionList TraitSetID="90005">
          <ClassifiedCondition>NAXE-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-19" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2019-06-17" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">27290639</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27616477</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33798445</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2020-11-21">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90005" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70876" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NAXE-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NAXE-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="63859" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43179" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy</ElementValue>
                <XRef ID="MONDO:0014960" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS617186" DB="OMIM" />
              </Name>
              <XRef ID="CN263076" DB="MedGen" />
              <XRef ID="MONDO:0014960" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS617186" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33246" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1</ElementValue>
                <XRef ID="MONDO:0020781" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NAD(P)HX epimerase deficiency</ElementValue>
                <XRef ID="555407" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEBEL</ElementValue>
                <XRef Type="MIM" ID="617186" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PEBEL1</ElementValue>
                <XRef Type="MIM" ID="617186" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17991" />
                <XRef ID="17991" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="555407" DB="Orphanet" />
              <XRef ID="C4310675" DB="MedGen" />
              <XRef ID="MONDO:0020781" DB="MONDO" />
              <XRef Type="MIM" ID="617186" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1803299" SubmissionDate="2019-04-08" DateLastUpdated="2019-06-17" DateCreated="2019-06-17">
        <ClinVarSubmissionID localKey="NM_144772.2:c.326dup|MedGen:C4310675" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000923734" DateUpdated="2019-06-17" DateCreated="2019-06-17" Type="SCV" Version="1" SubmitterName="Genomic Research Center, Shahid Beheshti University of Medical Sciences" OrgID="504864" OrganizationCategory="laboratory" OrgAbbreviation="GRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144772.2:c.326dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C4310675" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NGS_2019</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2853987" SubmissionDate="2020-07-31" DateLastUpdated="2020-11-21" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="NM_144772.2:c.326dup|ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001445887" DateUpdated="2020-11-21" DateCreated="2020-11-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 3 of 6 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function. This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (6/251464) and thus is presumed to be rare. Based on the predicted consequence of the variant and phenotypic overlap, the c.326dup (p.Thr110TyrfsTer11) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOA1BP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144772.2:c.326dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7860354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7683803" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="20953561|NAXE-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004108501" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The NAXE c.326dupC variant is predicted to result in a frameshift and premature protein termination (p.Thr110Tyrfs*11). This variant was reported in an individual with Congenital heart disease (Edwards et al 2020. PubMed ID: 32368696). This variant is reported in 0.014% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-156562185-G-GC). Frameshift variants in NAXE are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144772.2:c.326dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NAXE-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3964947" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="64c7372042b5cd86abc3482f147c8fe367e7462980561a4db6423c018593d331|OMIM:617186" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002017696" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144772.2:c.326dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617186" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4178285" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3106202|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002163748" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27290639</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27616477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33798445</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 634634). This variant has not been reported in the literature in individuals affected with NAXE-related conditions. This variant is present in population databases (rs779820587, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Thr110Tyrfs*11) in the NAXE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAXE are known to be pathogenic (PMID: 27290639, 27616477, 33798445).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.156562185_156562186insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2853987" TraitType="Disease" MappingType="Name" MappingValue="ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY" MappingRef="Preferred">
        <MedGen CUI="CN263076" Name="Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7683803" TraitType="Disease" MappingType="Name" MappingValue="NAXE-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NAXE-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3964947" TraitType="Disease" MappingType="XRef" MappingValue="617186" MappingRef="OMIM">
        <MedGen CUI="C4310675" Name="Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4178285" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1803299" TraitType="Disease" MappingType="Name" MappingValue="Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy" MappingRef="Preferred">
        <MedGen CUI="CN263076" Name="Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

